首页> 外文OA文献 >Field efficacy of four anthelmintics and confirmation of drug-resistant nematodes by controlled efficacy test and pyrosequencing on a sheep and goat farm in Denmark
【2h】

Field efficacy of four anthelmintics and confirmation of drug-resistant nematodes by controlled efficacy test and pyrosequencing on a sheep and goat farm in Denmark

机译:丹麦绵羊和山羊养殖场通过控制效力试验和焦磷酸测序确定4种驱虫药和抗药性线虫的田间药效

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We describe a case of anthelmintic resistance on one of the largest organic small ruminant farms in Denmark. The flock was established in 2007 by purchase of animals from other Danish farms and had history of clinical parasitism, high mortality of young stock and anthelmintic treatment failure. In October 2011, 40 lambs and 40 kids were selected for a faecal egg count reduction test (FECRT) with fenbendazole (FBZ), ivermectin (IVM), moxidectin (MOX) and levamisole (LEV). Lambs were treated with the recommended sheep dose of each product while kids received the sheep dose of IVM, 1.5× sheep dose of MOX and 2× sheep dose of FBZ and LEV. Untreated lambs and kids were also included and three methods for calculating faecal egg count (FEC) reduction were compared. In a subsequent investigation, a controlled efficacy test (CET) with FBZ and IVM was performed in lambs infected with Haemonchus contortus and Trichostrongylus colubriformis isolated from adult goats on the farm. Recovered specimens of H. contortus were subjected to pyrosequencing for detection of single nucleotide polymorphisms (SNPs) related to benzimidazole (BZ) resistance. During the FECRT, FECs in untreated lambs dropped significantly by 47%. No FEC reduction was detected in untreated kids. After FBZ treatments, FEC reductions in lambs and kids ranged from 15 to 54% and 49–56%, respectively, according to the different calculation methods. Post IVM treatments, FEC reductions in lambs and kids varied between 71–90% and 81–83%, correspondingly. LEV and MOX reduced FECs by 98–100% in both species. In the CET, FBZ reduced H. contortus worm counts by 52–56% and no reduction in T. colubriformis counts were detected after treatment. IVM eliminated 100% of H. contortus and reduced T. colubriformis counts by 84–92%, according to different calculation methods. Pyrosequencing of isolated H. contortus revealed increased frequencies of the BZ resistance-related SNP in codon 200 of the β-tubulin isotype 1 gene. Frequency of BZ resistance-related SNPs in codons 167 and 198 were very low and did not exceed levels as obtained in the susceptible reference isolate. Anthelmintic resistance was confirmed in this recently established organic farm and low field efficacy of FBZ was verified by CET and pyrosequencing. BZ-resistant populations of H. contortus and T. colubriformis were isolated for the first time in Denmark. Problems with correct dosing of goats, the observed FEC reduction in untreated lambs and the relevance of including a control group in the FECRT are discussed.
机译:我们描述了丹麦最大的有机小型反刍动物农场之一的驱虫药耐药性病例。该羊群成立于2007年,是从其他丹麦农场购买的动物而建立的,具有临床寄生虫病史,幼畜死亡率高和驱虫药治疗失败。 2011年10月,选择40只羔羊和40个孩子与芬苯达唑(FBZ),伊维菌素(IVM),莫昔克丁(MOX)和左旋咪唑(LEV)一起进行粪便卵数减少测试(FECRT)。羔羊用每种产品的推荐绵羊剂量治疗,而孩子们则接受IVM绵羊剂量,MOX 1.5倍绵羊剂量和FBZ和LEV 2倍绵羊剂量。还包括未经处理的羔羊和儿童,比较了三种减少粪便卵数(FEC)的方法。在随后的调查中,对从农场成年山羊身上分离出的弯曲变形杆菌(Haemonchus contortus)和粘虫(Trichostrongylus colubriformis)感染的羔羊进行了FBZ和IVM的对照功效测试(CET)。回收的捻转血矛线虫标本进行焦磷酸测序,以检测与苯并咪唑(BZ)耐药相关的单核苷酸多态性(SNP)。在FECRT期间,未经处理的羔羊的FEC显着下降了47%。在未接受治疗的儿童中未检测到FEC降低。根据不同的计算方法,经过FBZ处理后,羔羊和儿童的FEC减少量分别为15%至54%和49-56%。 IVM治疗后,羔羊和儿童的FEC减少幅度分别在71%至90%和81%至83%之间。 LEV和MOX在这两个物种中均使FEC降低了98-100%。在CET中,FBZ使锥状螺旋体蠕虫计数减少了52–56%,并且治疗后未检测到co.colubriformis计数减少。根据不同的计算方法,IVM消除了100%的捻转嗜血杆菌,并减少了T. colubriformis计数84-92%。分离的捻转嗜血杆菌的焦磷酸测序揭示了β-微管蛋白同种型1基因200号密码子中与BZ抗性相关的SNP的频率增加。密码子167和198中BZ抗性相关SNP的频率非常低,没有超过易感参考菌株中获得的水平。在这个最近建立的有机农场中确认了抗寄生虫性,并且通过CET和焦磷酸测序证实了FBZ的低田间药效。在丹麦首次分离到了BZ抵抗性的H. contortus和T. colubriformis种群。讨论了正确配给山羊的问题,观察到的未处理羊羔的FEC降低以及在FECRT中包括对照组的相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号